PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line

Simona Di Lascio, Elena Saba, Debora Belperio, Andrea Raimondi, Helen Lucchetti, Diego Fornasari, Roberta Benfante

Research output: Contribution to journalArticle

Abstract

PHOX2B and its paralogue gene PHOX2A are two homeodomain proteins in the network regulating the development of autonomic ganglia that have been associated with the pathogenesis of neuroblastoma (NB), because of their over-expression in different NB cell lines and tumour samples. We used the SK-N-BE(2)C cell line to show that all-trans retinoic acid (ATRA), a drug that is widely used to inhibit growth and induce differentiation in NBs, regulates both PHOX2A and PHOX2B expression, albeit by means of different mechanisms: it up-regulates PHOX2A and down-regulates PHOX2B. Both mechanisms act at transcriptional level, but prolonged ATRA treatment selectively degrades the PHOX2A protein, whereas the corresponding mRNA remains up-regulated. Further, we show that PHOX2A is capable of modulating PHOX2B expression, but this mechanism is not involved in the PHOX2B down-regulation induced by retinoic acid. Our findings demonstrate that PHOX2A expression is finely controlled during retinoic acid differentiation and this, together with PHOX2B down-regulation, reinforces the idea that they may be useful biomarkers for NB staging, prognosis and treatment decision making.
Original languageEnglish
Pages (from-to)62 - 71
Number of pages10
JournalExperimental Cell Research
Volume342
Issue number1
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Tretinoin
Neuroblastoma
Cell Line
Down-Regulation
Autonomic Ganglia
Homeodomain Proteins
Tumor Cell Line
Decision Making
Up-Regulation
Biomarkers
Messenger RNA
Growth
Pharmaceutical Preparations
Genes
Proteins

Keywords

  • Differentiation
  • Homeodomain protein
  • Human
  • Neuroblastoma
  • Retinoic acid
  • Transcription
  • Transcription factor

ASJC Scopus subject areas

  • Cell Biology

Cite this

PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line. / Di Lascio, Simona; Saba, Elena; Belperio, Debora; Raimondi, Andrea; Lucchetti, Helen; Fornasari, Diego; Benfante, Roberta.

In: Experimental Cell Research, Vol. 342, No. 1, 01.03.2016, p. 62 - 71.

Research output: Contribution to journalArticle

Di Lascio, Simona ; Saba, Elena ; Belperio, Debora ; Raimondi, Andrea ; Lucchetti, Helen ; Fornasari, Diego ; Benfante, Roberta. / PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line. In: Experimental Cell Research. 2016 ; Vol. 342, No. 1. pp. 62 - 71.
@article{5a2e193de7ff45bcb27832000a1333a1,
title = "PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line",
abstract = "PHOX2B and its paralogue gene PHOX2A are two homeodomain proteins in the network regulating the development of autonomic ganglia that have been associated with the pathogenesis of neuroblastoma (NB), because of their over-expression in different NB cell lines and tumour samples. We used the SK-N-BE(2)C cell line to show that all-trans retinoic acid (ATRA), a drug that is widely used to inhibit growth and induce differentiation in NBs, regulates both PHOX2A and PHOX2B expression, albeit by means of different mechanisms: it up-regulates PHOX2A and down-regulates PHOX2B. Both mechanisms act at transcriptional level, but prolonged ATRA treatment selectively degrades the PHOX2A protein, whereas the corresponding mRNA remains up-regulated. Further, we show that PHOX2A is capable of modulating PHOX2B expression, but this mechanism is not involved in the PHOX2B down-regulation induced by retinoic acid. Our findings demonstrate that PHOX2A expression is finely controlled during retinoic acid differentiation and this, together with PHOX2B down-regulation, reinforces the idea that they may be useful biomarkers for NB staging, prognosis and treatment decision making.",
keywords = "Differentiation, Homeodomain protein, Human, Neuroblastoma, Retinoic acid, Transcription, Transcription factor",
author = "{Di Lascio}, Simona and Elena Saba and Debora Belperio and Andrea Raimondi and Helen Lucchetti and Diego Fornasari and Roberta Benfante",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.yexcr.2016.02.014",
language = "English",
volume = "342",
pages = "62 -- 71",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line

AU - Di Lascio, Simona

AU - Saba, Elena

AU - Belperio, Debora

AU - Raimondi, Andrea

AU - Lucchetti, Helen

AU - Fornasari, Diego

AU - Benfante, Roberta

PY - 2016/3/1

Y1 - 2016/3/1

N2 - PHOX2B and its paralogue gene PHOX2A are two homeodomain proteins in the network regulating the development of autonomic ganglia that have been associated with the pathogenesis of neuroblastoma (NB), because of their over-expression in different NB cell lines and tumour samples. We used the SK-N-BE(2)C cell line to show that all-trans retinoic acid (ATRA), a drug that is widely used to inhibit growth and induce differentiation in NBs, regulates both PHOX2A and PHOX2B expression, albeit by means of different mechanisms: it up-regulates PHOX2A and down-regulates PHOX2B. Both mechanisms act at transcriptional level, but prolonged ATRA treatment selectively degrades the PHOX2A protein, whereas the corresponding mRNA remains up-regulated. Further, we show that PHOX2A is capable of modulating PHOX2B expression, but this mechanism is not involved in the PHOX2B down-regulation induced by retinoic acid. Our findings demonstrate that PHOX2A expression is finely controlled during retinoic acid differentiation and this, together with PHOX2B down-regulation, reinforces the idea that they may be useful biomarkers for NB staging, prognosis and treatment decision making.

AB - PHOX2B and its paralogue gene PHOX2A are two homeodomain proteins in the network regulating the development of autonomic ganglia that have been associated with the pathogenesis of neuroblastoma (NB), because of their over-expression in different NB cell lines and tumour samples. We used the SK-N-BE(2)C cell line to show that all-trans retinoic acid (ATRA), a drug that is widely used to inhibit growth and induce differentiation in NBs, regulates both PHOX2A and PHOX2B expression, albeit by means of different mechanisms: it up-regulates PHOX2A and down-regulates PHOX2B. Both mechanisms act at transcriptional level, but prolonged ATRA treatment selectively degrades the PHOX2A protein, whereas the corresponding mRNA remains up-regulated. Further, we show that PHOX2A is capable of modulating PHOX2B expression, but this mechanism is not involved in the PHOX2B down-regulation induced by retinoic acid. Our findings demonstrate that PHOX2A expression is finely controlled during retinoic acid differentiation and this, together with PHOX2B down-regulation, reinforces the idea that they may be useful biomarkers for NB staging, prognosis and treatment decision making.

KW - Differentiation

KW - Homeodomain protein

KW - Human

KW - Neuroblastoma

KW - Retinoic acid

KW - Transcription

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=84958559590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958559590&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2016.02.014

DO - 10.1016/j.yexcr.2016.02.014

M3 - Article

VL - 342

SP - 62

EP - 71

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 1

ER -